Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. (Q27851801)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q42947998)
(Q42068411)
(Q46460242)
(Q56614941)
(Q91632374)
(Q117251004)
(Q94947567)
(Q114523104)
(Q117251010)
(Q114439514)
(Q90321335)
(P304) 1893-1901
(P407) (Q1860)
(P433) 9829
(P478) 379
(P577) Tuesday, May 1, 2012
(P921) (Q1073)
(Q5452194)
(Q181600)
(Q1620196)
(P1433) (Q939416)
(P1476) "Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial" (language: en)
(P2093) Kevin B Kim
Tobias H Arkenau
Steven J O'Day
Samuel C Blackman
C Martin Curtis
Bo Ma
(P2860) (Q24631953)
(Q27851628)
(Q24629474)
(Q24298749)
(Q27659493)
(Q27860458)
(Q27860760)
(Q27860904)
(Q28131668)
(Q28289851)
(Q29620033)
(Q29614757)
(Q29615032)
(Q29616828)
(Q29614803)
(Q39692674)
(Q34632917)
(Q38406445)
(Q40543086)
(Q33361043)
(Q44303940)
(Q49099951)
(Q54610975)
(Q51597972)
(Q28251989)
(Q85226494)
(Q48594003)
(Q24594790)
(Q73598986)
(Q36489360)
other details
aliases Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
description scientific article

External Links